Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil plus remimazolam intravenous anesthesia for hysteroscopic surgery
ChiCTR2200062983Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Guangxi Medical University
- Start
- Aug 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of remimazolam and remifentanil (3 arms), sponsored by The First Affiliated Hospital of Guangxi Medical University. Primary endpoint: Time to loss of consciousness. Started Aug 2022; status: recruiting.
02
Drugs
remimazolamremifentanil
Beyond the preview
Go deeper on ChiCTR2200062983.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200062983.